Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Kidney Forum. 2003; 4 (1): 21-28
em Inglês | IMEMR | ID: emr-63236

RESUMO

We selected 40 cases of chronic renal failure [CRF] [25 males and 15 females] on thrice weekly haemodialysis [HD] using acetate for at least 1 year before study onset. All cases were allowed unrestricted protein intake starting one month before they were randomly divided into 2 groups matched for age, gender, body weight [BW] and socioeconomic status, Group 1 were shifted to bicarbonate dialysis while Group 2 patients were kept on acetate dialysis for 3 months then cross over was done for the following 3 months. Both biocarnonate and acetate were used at a fixed concentration of 36 mmol/L. Prescribed Kt/V was kept constant throughout the 6 months. Pre and post dialysis [Dx] blood pH and serum bicarbonate [Sbic].predialysis serum prealbumin [Spalb], and transferring [Stf], triceps skin fold thickness [TSF], mid arm muscle circumference [MAMC] as well as protein catabolic rate [PCR and nPCR] and urea reduction ratio [URR] were estimated at the onset and at the end of each 3 month period. Delivered kt/V was estimated from URR. Pre Dx Sbic and pH were significantly higher during bicarbonate dialysis compared to acetate dialysis [p<0.001]. Spalb increased significantly in Group 1 during bicarbonate and decreased significantly during acetate dialysis [p<0.00011 and 0.06,respectively] while in Group 2 it increased significantly in both periods [p<0.05 and 0.004.respectively]. Stf didn't show any significant change throughout the study. TSF, MAC and MAMC increased significantly in Group 1 during bicarhonate dialysis and decreased significantly during acetate dialysis [p<0.001,0.02.0.001,0.05,0.004 and 0.03,respectively for TSF, MAC and MAMC at 0,3 months and MAMC at 0,3 months and 6 months] while in Group 2 they did not change during acetate dialysis and increased significantly during bicarbonate dialysis [p<0.05,<0.002.>0.05, <0.03, >0.05 and <0.05, respectively]. nPCR increased significantly in Group 1 during bicarbonate dialysis and did not change during acetate dialysis [p<0.001 and >0.05, respectively] while in Group 2 nPCR did not change during acetate dialysis and increased significantly during bicarbonate dialysis [p>0.05 and >0.05, respectively]. Although prescribed Kt/V did not change throughout the study, delivered Kt/V increased significantly in Group 1 during bicarbonate dialysis and decreased significantly during acetate dialysis [p<0.001 and < 0.02, respectively]. In Group 2 delivered Kt/V did not change during acetate dialysis and increased significantly during bicarbonate dialysis [p>0.5 and <0.0001, respectively]. Conclusions: 1. Bicarbonate dialysis offers better blood pH and Sbic levels 2. Optimized serum pH and bicarbonate offers improvement in protein intake evidenced by increased nPCR associated with improved protein anabolism as evidenced by increased Spalb, TSF, MAC and MAMC. 3. Increased delivered Kt/V is likely due to better patient compliance during bicarbonate haemodialysis


Assuntos
Humanos , Masculino , Feminino , Soluções para Diálise , Bicarbonato de Sódio , Acetato de Sódio , Gasometria , Falência Renal Crônica , Transferrina , Dobras Cutâneas , Desnutrição Proteico-Calórica , Estudos Prospectivos
2.
African Journal of Urology. 1998; 4 (2): 70-75
em Inglês | IMEMR | ID: emr-47341

RESUMO

Thirty-eight [38] new kidney recipients, and 12 normal controls were included in this study to determine the value of various immunologic parameters in the early monitoring of active CMV infection. CMV antigen and IgG and IgM antibodies were measured weekly in both recipient and control groups. In addition, the level of Soluble Interleukin 2 Receptor [SIL2R] and T cell subsets were measured at monthly intervals. This was correlated to their clinical condition. Eight [8] of the 38 recipients became positive for CMV antigen in peripheral blood leukocytes. This usually preceded the appearance of CMV IgM antibodies by at least one week. On further follow-up, CMV IgM decreased to normal levels in 4 to 6 weeks in 5 recipients. The remaining 3 died from CMV syndrome. In addition, the serum SIL2R level in the recipients before transplantation was significantly higher than in the control group. One month after transplantation, the CMV negative antigen group showed a significant lowering of the SIL2R level, while the CMV positive group showed a significant rise in this level. One month later, SIL2R decreased significantly. Finally, T cell subset determination in the CMV positive group showed a slight lowering of helper T cells and a marked elevation of the suppressor cells compared to the CMV negative group. This was also associated with a significant decrease in the helper/suppressor ratio. CMV antigenaemia is a sensitive and specific marker of CMV infection that significantly precedes the appearance of CMV antibodies. It is of great value in the monitoring of renal transplant recipients who are at high risk of CMV infection


Assuntos
Humanos , Masculino , Feminino , Infecções por Citomegalovirus , Receptores de Interleucina-2 , Técnicas Imunoenzimáticas , Imunoglobulina E , Imunoglobulina M , Antígenos CD4 , Antígenos CD8
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA